Cargando…

Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis

BACKGROUND: Patients with locally advanced esophageal or gastroesophageal adenocarcinoma benefit from multimodal therapy concepts including neoadjuvant chemoradiation (nCRT), respectively, perioperative chemotherapy (pCT). However, it remains unclear which treatment is superior concerning postoperat...

Descripción completa

Detalles Bibliográficos
Autores principales: Plum, Patrick Sven, Damanakis, Alexander, Buschmann, Lisa, Ernst, Angela, Datta, Rabi Raj, Schiffmann, Lars Mortimer, Zander, Thomas, Fuchs, Hans, Chon, Seung-Hun, Alakus, Hakan, Schröder, Wolfgang, Hölscher, Arnulf Heinrich, Bruns, Christiane Josephine, Bludau, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016042/
https://www.ncbi.nlm.nih.gov/pubmed/34223965
http://dx.doi.org/10.1007/s00432-021-03720-5
_version_ 1784688443836596224
author Plum, Patrick Sven
Damanakis, Alexander
Buschmann, Lisa
Ernst, Angela
Datta, Rabi Raj
Schiffmann, Lars Mortimer
Zander, Thomas
Fuchs, Hans
Chon, Seung-Hun
Alakus, Hakan
Schröder, Wolfgang
Hölscher, Arnulf Heinrich
Bruns, Christiane Josephine
Bludau, Marc
author_facet Plum, Patrick Sven
Damanakis, Alexander
Buschmann, Lisa
Ernst, Angela
Datta, Rabi Raj
Schiffmann, Lars Mortimer
Zander, Thomas
Fuchs, Hans
Chon, Seung-Hun
Alakus, Hakan
Schröder, Wolfgang
Hölscher, Arnulf Heinrich
Bruns, Christiane Josephine
Bludau, Marc
author_sort Plum, Patrick Sven
collection PubMed
description BACKGROUND: Patients with locally advanced esophageal or gastroesophageal adenocarcinoma benefit from multimodal therapy concepts including neoadjuvant chemoradiation (nCRT), respectively, perioperative chemotherapy (pCT). However, it remains unclear which treatment is superior concerning postoperative morbidity. METHODS: In this study, we compared the postsurgical survival (30-day/90-day/1-year mortality) (primary endpoint), treatment response, and surgical complications (secondary endpoints) of patients who either received nCRT (CROSS protocol) or pCT (FLOT protocol) due to esophageal/gastroesophageal adenocarcinoma. Between January 2013 and December 2017, 873 patients underwent Ivor Lewis esophagectomy in our high-volume center. 339 patients received nCRT and 97 underwent pCT. After 1:1 propensity score matching (matching criteria: sex, age, BMI, ASA score, and Charlson score), 97 patients per subgroup were included for analysis. RESULTS: After matching, tumor response (ypT/ypN) did not differ significantly between nCRT and pCT (p = 0.118, respectively, p = 0.174). Residual nodal metastasis occurred more often after pCT (p = 0.001). Postsurgical mortality was comparable within both groups. No patient died within 30 or 90 days after surgery while the 1-year survival rate was 72.2% for nCRT and 68.0% for pCT (p = 0.47). Only grade 3a complications according to Clavien–Dindo were increased after pCT (p = 0.04). There was a trend towards a higher rate of pylorospasm within the pCT group (nCRT: 23.7% versus pCT: 37.1%) (p = 0.061). Multivariate analysis identified pCT, younger age, and Charlson score as independent variables for pylorospasm. CONCLUSION: Both nCRT and pCT are safe and efficient within the multimodal treatment of esophageal/gastroesophageal adenocarcinoma. We did not observe differences in postoperative morbidity. However, functional aspects such as gastric emptying might be more frequent after pCT.
format Online
Article
Text
id pubmed-9016042
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-90160422022-05-02 Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis Plum, Patrick Sven Damanakis, Alexander Buschmann, Lisa Ernst, Angela Datta, Rabi Raj Schiffmann, Lars Mortimer Zander, Thomas Fuchs, Hans Chon, Seung-Hun Alakus, Hakan Schröder, Wolfgang Hölscher, Arnulf Heinrich Bruns, Christiane Josephine Bludau, Marc J Cancer Res Clin Oncol Original Article – Clinical Oncology BACKGROUND: Patients with locally advanced esophageal or gastroesophageal adenocarcinoma benefit from multimodal therapy concepts including neoadjuvant chemoradiation (nCRT), respectively, perioperative chemotherapy (pCT). However, it remains unclear which treatment is superior concerning postoperative morbidity. METHODS: In this study, we compared the postsurgical survival (30-day/90-day/1-year mortality) (primary endpoint), treatment response, and surgical complications (secondary endpoints) of patients who either received nCRT (CROSS protocol) or pCT (FLOT protocol) due to esophageal/gastroesophageal adenocarcinoma. Between January 2013 and December 2017, 873 patients underwent Ivor Lewis esophagectomy in our high-volume center. 339 patients received nCRT and 97 underwent pCT. After 1:1 propensity score matching (matching criteria: sex, age, BMI, ASA score, and Charlson score), 97 patients per subgroup were included for analysis. RESULTS: After matching, tumor response (ypT/ypN) did not differ significantly between nCRT and pCT (p = 0.118, respectively, p = 0.174). Residual nodal metastasis occurred more often after pCT (p = 0.001). Postsurgical mortality was comparable within both groups. No patient died within 30 or 90 days after surgery while the 1-year survival rate was 72.2% for nCRT and 68.0% for pCT (p = 0.47). Only grade 3a complications according to Clavien–Dindo were increased after pCT (p = 0.04). There was a trend towards a higher rate of pylorospasm within the pCT group (nCRT: 23.7% versus pCT: 37.1%) (p = 0.061). Multivariate analysis identified pCT, younger age, and Charlson score as independent variables for pylorospasm. CONCLUSION: Both nCRT and pCT are safe and efficient within the multimodal treatment of esophageal/gastroesophageal adenocarcinoma. We did not observe differences in postoperative morbidity. However, functional aspects such as gastric emptying might be more frequent after pCT. Springer Berlin Heidelberg 2021-07-05 2022 /pmc/articles/PMC9016042/ /pubmed/34223965 http://dx.doi.org/10.1007/s00432-021-03720-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article – Clinical Oncology
Plum, Patrick Sven
Damanakis, Alexander
Buschmann, Lisa
Ernst, Angela
Datta, Rabi Raj
Schiffmann, Lars Mortimer
Zander, Thomas
Fuchs, Hans
Chon, Seung-Hun
Alakus, Hakan
Schröder, Wolfgang
Hölscher, Arnulf Heinrich
Bruns, Christiane Josephine
Bludau, Marc
Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis
title Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis
title_full Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis
title_fullStr Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis
title_full_unstemmed Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis
title_short Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis
title_sort short-term outcome of ivor lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis
topic Original Article – Clinical Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016042/
https://www.ncbi.nlm.nih.gov/pubmed/34223965
http://dx.doi.org/10.1007/s00432-021-03720-5
work_keys_str_mv AT plumpatricksven shorttermoutcomeofivorlewisesophagectomyfollowingneoadjuvantchemoradiationversusperioperativechemotherapyinpatientswithlocallyadvancedadenocarcinomaoftheesophagusandgastroesophagealjunctionapropensityscorematchedanalysis
AT damanakisalexander shorttermoutcomeofivorlewisesophagectomyfollowingneoadjuvantchemoradiationversusperioperativechemotherapyinpatientswithlocallyadvancedadenocarcinomaoftheesophagusandgastroesophagealjunctionapropensityscorematchedanalysis
AT buschmannlisa shorttermoutcomeofivorlewisesophagectomyfollowingneoadjuvantchemoradiationversusperioperativechemotherapyinpatientswithlocallyadvancedadenocarcinomaoftheesophagusandgastroesophagealjunctionapropensityscorematchedanalysis
AT ernstangela shorttermoutcomeofivorlewisesophagectomyfollowingneoadjuvantchemoradiationversusperioperativechemotherapyinpatientswithlocallyadvancedadenocarcinomaoftheesophagusandgastroesophagealjunctionapropensityscorematchedanalysis
AT dattarabiraj shorttermoutcomeofivorlewisesophagectomyfollowingneoadjuvantchemoradiationversusperioperativechemotherapyinpatientswithlocallyadvancedadenocarcinomaoftheesophagusandgastroesophagealjunctionapropensityscorematchedanalysis
AT schiffmannlarsmortimer shorttermoutcomeofivorlewisesophagectomyfollowingneoadjuvantchemoradiationversusperioperativechemotherapyinpatientswithlocallyadvancedadenocarcinomaoftheesophagusandgastroesophagealjunctionapropensityscorematchedanalysis
AT zanderthomas shorttermoutcomeofivorlewisesophagectomyfollowingneoadjuvantchemoradiationversusperioperativechemotherapyinpatientswithlocallyadvancedadenocarcinomaoftheesophagusandgastroesophagealjunctionapropensityscorematchedanalysis
AT fuchshans shorttermoutcomeofivorlewisesophagectomyfollowingneoadjuvantchemoradiationversusperioperativechemotherapyinpatientswithlocallyadvancedadenocarcinomaoftheesophagusandgastroesophagealjunctionapropensityscorematchedanalysis
AT chonseunghun shorttermoutcomeofivorlewisesophagectomyfollowingneoadjuvantchemoradiationversusperioperativechemotherapyinpatientswithlocallyadvancedadenocarcinomaoftheesophagusandgastroesophagealjunctionapropensityscorematchedanalysis
AT alakushakan shorttermoutcomeofivorlewisesophagectomyfollowingneoadjuvantchemoradiationversusperioperativechemotherapyinpatientswithlocallyadvancedadenocarcinomaoftheesophagusandgastroesophagealjunctionapropensityscorematchedanalysis
AT schroderwolfgang shorttermoutcomeofivorlewisesophagectomyfollowingneoadjuvantchemoradiationversusperioperativechemotherapyinpatientswithlocallyadvancedadenocarcinomaoftheesophagusandgastroesophagealjunctionapropensityscorematchedanalysis
AT holscherarnulfheinrich shorttermoutcomeofivorlewisesophagectomyfollowingneoadjuvantchemoradiationversusperioperativechemotherapyinpatientswithlocallyadvancedadenocarcinomaoftheesophagusandgastroesophagealjunctionapropensityscorematchedanalysis
AT brunschristianejosephine shorttermoutcomeofivorlewisesophagectomyfollowingneoadjuvantchemoradiationversusperioperativechemotherapyinpatientswithlocallyadvancedadenocarcinomaoftheesophagusandgastroesophagealjunctionapropensityscorematchedanalysis
AT bludaumarc shorttermoutcomeofivorlewisesophagectomyfollowingneoadjuvantchemoradiationversusperioperativechemotherapyinpatientswithlocallyadvancedadenocarcinomaoftheesophagusandgastroesophagealjunctionapropensityscorematchedanalysis